CRISPR-Cas9: Function in Bacteria and Genome Editing

1. CRISPR-Cas9 in Bacteria: Natural Defense Mechanism

1.1. Overview

• CRISPR-Cas9 is a naturally occurring defense system in bacteria and archaea against viral attacks (specifically bacteriophages).
• It provides a form of adaptive immunity, allowing bacteria to recognize and neutralize foreign DNA from viruses or plasmids.

1.2. Components of the CRISPR-Cas9 System

• CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats):
  • DNA loci containing short, repeated sequences of DNA.
  • These repeats are separated by spacer DNA, which are unique sequences derived from past viral infections.
• Cas (CRISPR-associated) genes:
  • Genes encoding Cas proteins, which are enzymes involved in various stages of the CRISPR-Cas9 defense mechanism.
  • Cas9 is a key Cas protein – an endonuclease that can cut DNA.

1.3. Mechanism of Action in Bacteria

1. Acquisition:
   • When a bacterium survives a viral infection, it integrates a segment of the viral DNA into its CRISPR locus as a new spacer.
   • This “memorizes” the infection for future encounters.
2. Expression:
   • The CRISPR locus is transcribed into a long RNA molecule called pre-crRNA (CRISPR RNA).
   • The pre-crRNA is processed into shorter crRNAs, each containing a single spacer sequence flanked by repeat sequences.
3. Targeting:
   • Each crRNA associates with a Cas protein (e.g., Cas9) to form a complex.
   • The crRNA guides the Cas9 protein to the target DNA sequence that matches the spacer sequence in the crRNA.
4. Interference:
   • If the crRNA finds a complementary sequence in the invading viral DNA, the Cas9 protein cleaves the viral DNA, neutralizing the threat.
   • Cas9 acts as an endonuclease, creating a double-stranded break in the DNA.

1.4. Diagrammatic Representation

(Description: A diagram showing the CRISPR locus with repeats and spacers, transcription into pre-crRNA, processing into crRNA, complex formation with Cas9, and the Cas9-crRNA complex targeting and cleaving viral DNA.)

KEY TAKEAWAY: CRISPR-Cas9 is a bacterial immune system that uses stored viral DNA sequences to recognize and destroy matching sequences in future infections.

2. Application in Genome Editing

2.1. Modifying the CRISPR-Cas9 System for Genome Editing

• Scientists have adapted the bacterial CRISPR-Cas9 system to edit genes in other organisms, including plants, animals, and humans.
• The key modification is the use of a single guide RNA (sgRNA), which combines the crRNA and tracrRNA (another RNA molecule involved in the bacterial system) into a single molecule.

2.2. Components for Genome Editing

• Cas9 protein: The endonuclease that cuts DNA. Often derived from Streptococcus pyogenes (SpCas9).
• sgRNA (single guide RNA): A synthetic RNA molecule consisting of:
  • A scaffold sequence that binds to the Cas9 protein.
  • A guide sequence (approximately 20 nucleotides) that is complementary to the target DNA sequence.

2.3. Mechanism of Genome Editing

1. Design and Delivery:
   • Researchers design an sgRNA with a guide sequence that matches the gene they want to edit.
   • The sgRNA and Cas9 protein are delivered into the target cell. This can be done using plasmids, viral vectors, or direct injection.
2. Targeting:
   • The sgRNA guides the Cas9 protein to the specific DNA sequence in the genome.
   • The Cas9 protein binds to the DNA adjacent to a specific sequence called the Protospacer Adjacent Motif (PAM). For SpCas9, the PAM sequence is NGG (N stands for any nucleotide).
3. Cleavage:
   • The Cas9 protein makes a double-stranded break in the DNA, a few bases upstream of the PAM sequence.
4. Repair:
   • The cell’s natural DNA repair mechanisms are activated. There are two main pathways:
     • Non-homologous end joining (NHEJ): This pathway is error-prone and often introduces small insertions or deletions (indels) that can disrupt the gene, effectively “knocking it out.”
     • Homology-directed repair (HDR): If a donor DNA template with the desired sequence is provided along with the Cas9 and sgRNA, the cell can use this template to repair the break, inserting the desired sequence into the genome.

2.4. Diagrammatic Representation

(Description: A diagram showing the sgRNA-Cas9 complex, targeting the DNA sequence adjacent to the PAM sequence, the Cas9 protein making a double-stranded break, and the two repair pathways: NHEJ leading to gene disruption and HDR leading to gene insertion.)

2.5. Applications of CRISPR-Cas9 Genome Editing

• Gene knockout: Disrupting a gene’s function to study its role.
• Gene insertion: Adding a new gene or correcting a mutated gene.
• Gene regulation: Modifying gene expression without changing the DNA sequence (e.g., using a catalytically inactive Cas9 (dCas9) to block transcription).
• Disease treatment: Correcting genetic defects in diseases like cystic fibrosis, Huntington’s disease, and sickle cell anemia.
• Agriculture: Improving crop yields, disease resistance, and nutritional content.
• Research: Studying gene function and developing new therapies.

2.6. Advantages of CRISPR-Cas9 over other gene editing techniques

• Simplicity and ease of use: Easier to design and implement than other methods.
• Efficiency: High success rate in targeting and editing genes.
• Cost-effectiveness: Relatively inexpensive compared to other gene editing technologies.
• Multiplexing: Ability to target multiple genes simultaneously.

EXAM TIP: Be prepared to explain the steps of CRISPR-Cas9 genome editing, including the roles of the Cas9 protein, sgRNA, PAM sequence, and DNA repair pathways. Understand the difference between NHEJ and HDR.

3. Ethical Considerations

• While CRISPR-Cas9 technology holds great promise, it also raises ethical concerns, including:
  • Off-target effects: The Cas9 protein may cut DNA at unintended sites in the genome.
  • Germline editing: Editing genes in sperm, eggs, or embryos could have unintended consequences for future generations.
  • Equity and access: Ensuring that CRISPR-Cas9 technology is available to all who need it, regardless of socioeconomic status.
  • Social implications: Concerns about the potential for “designer babies” and other unintended social consequences.

VCAA FOCUS: VCAA often assesses understanding of both the scientific mechanism of CRISPR-Cas9 and the ethical implications of its use.